(IN BRIEF) Rheinmetall has been awarded a contract by the Bundeswehr to provide up to 120 mobile aid stations, with the first delivery scheduled for December 2025. The order, valued in the high double-digit million-euro range, includes ten ballistic-protected and … Read the full press release
Posted in Business, Defence, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Security & Safety, Technology
Tagged 2025, air conditioning unit, armoured systems, ballistic-protected systems, Bundeswehr, contract, delivery, Emergency Care, emergency surgery container, high double-digit million-euro range, medical equipment, medical response, military medical care, Military Personnel, mobile aid stations, modular medical facilities, MSE system, partnership, Power Generator, Rheinmetall, surgical care, training, unarmoured systems, unprotected systems
(IN BRIEF) Evonik has partnered with ST Pharm to enhance its RNA and nucleic acid therapeutic services, combining ST Pharm’s expertise in customized nucleic acids with Evonik’s advanced lipid and lipid nanoparticle (LNP) drug product development solutions. This collaboration aims … Read the full press release
Posted in Business, Chemicals, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged active ingredients, capping library screening, clinical trials, drug delivery, drug development, drug product development, enzymatic biotransformation, Evonik, Evonik capabilities, Fill & Finish, gene delivery, gene therapies, GMP manufacturing, Health Care Business, Kris S. Choi, life sciences sector, lipid nanoparticle, lipids, liposomes, LNP, mRNA development, mRNA-LNPs, North America manufacturing, nucleic acid medicines, nucleic acid therapeutics, nucleic acid therapies, Nutrition & Care division, oligonucleotides, partnership, pharmaceutical companies, RNA market, RNA therapeutics, siRNAs, small molecules, SmartCap® technology, South Korea, ST Pharm, strategic partnership, Yann d'Hervé
(IN BRIEF) Researchers at Empa and the Cantonal Hospital of St. Gallen are developing new nanocomplexes to combat antibiotic-resistant bacteria and protect eye tissue following cataract surgery. Supported by the Heinz A. Oertli Fund for Ophthalmology, these nanocomplexes, based on … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Antibiotic-Resistant Infections, Empa, Eye Surgery, Mihyun Lee, Nanocomplexes, safety
(IN BRIEF) CompuGroup Medical’s governing bodies have endorsed CVC Capital Partners’ voluntary public tender offer, recommending that shareholders accept the proposed price of €22.00 per share. Following a thorough evaluation of the offer, including fairness opinions from Deutsche Bank and … Read the full press release
Posted in Business, Germany, Healthcare, Management
Tagged Administrative Board, AI technology, cloud-based software, CompuGroup Medical, CVC Capital Partners, Daniela Hommel, delisting offer, Deutsche Bank, fairness opinions, Frank Gotthardt, Gotthardt family, growth strategy, J.P. Morgan, Managing Directors, minimum acceptance threshold, Philipp von Ilberg, Prof. Dr. Daniel Gotthardt, regulatory conditions, share acceptance period, Supervisory Board, tender offer, voluntary public tender offer
(IN BRIEF) The University of York has assumed a leading role in advancing adult social care research, with Professor Yvonne Birks becoming the first director of the National Institute for Health and Care Research (NIHR) School for Social Care Research … Read the full press release
(IN BRIEF) Fresenius Medical Care (FME) has been named the top company in Boston Consulting Group’s (BCG) Gender Diversity Index Germany for 2024, rising from 29th place the previous year. The recognition, featured in Manager Magazin, acknowledges FME’s progress in … Read the full press release
(IN BRIEF) The European Society of Cardiology (ESC) has raised concerns over the growing incidence of cancer therapy-induced cardiovascular disease (CVD), warning of a potential cardio-oncology “epidemic” due to increasing cancer survival rates and aging populations. To address this, the … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, Media, News, Science, Technology
Tagged Cardio-Oncology Crisis, Dr. Alexander Lyon, Dr. Teresa López-Fernandez, ESC, health
(IN BRIEF) The FDA has granted Breakthrough Therapy designation to tolebrutinib for treating adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS), following positive results from the HERCULES phase 3 study. The study showed tolebrutinib delayed disability progression by 31% and … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Dr. Erik Wallström, FDA, Progressive Multiple Sclerosis, safety, Sanofi, tolebrutinib
(IN BRIEF) Roche has received CE certification for its enhanced cobas® 6800/8800 systems 2.0, introducing significant improvements in laboratory diagnostics. The upgrade streamlines operations by reducing downtime, consolidating test menus, and increasing throughput, supported by innovative TAGS technology that detects … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged cobas Systems 2.0, Matt Sause, Molecular Diagnostics, Roche, safety
(IN BRIEF) Roche’s Vabysmo® (faricimab) prefilled syringe has received European Medicines Agency approval for treating three major retinal conditions: neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema caused by retinal vein occlusion (RVO). Serving over nine … Read the full press release
(IN BRIEF) A University of Liverpool study, funded by BSAVA PetSavers, examines the ageing process in dogs, identifying 12.5 years as the average age when veterinarians consider them senior, though this varies by breed. Smaller breeds like Jack Russell Terriers … Read the full press release
(IN BRIEF) Researchers from UCSF and the Technical University of Munich (TUM) have developed engineered regulatory immune cells to precisely modulate the immune system, addressing conditions like type 1 diabetes, autoimmune diseases, and organ transplant rejection. Unlike traditional immunosuppressants, this … Read the full press release
(IN BRIEF) ZEISS Research Microscopy Solutions and AI pathology leader Mindpeak have joined forces to develop an integrated Multiplex Immunofluorescence (mIF) solution. Combining ZEISS’ advanced imaging technologies with Mindpeak’s AI-driven pathology algorithms, the solution targets research, diagnostics, and clinical applications. … Read the full press release
(IN BRIEF) Evotec and Novo Nordisk’s LAB eN² program, a translational drug discovery accelerator, has selected its first three academic research projects focused on addressing cardiometabolic diseases. The projects, from Boston University, Harvard University in collaboration with Mass General Brigham, … Read the full press release
Posted in Business, Denmark, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Boston University, Cardiometabolic Research, Chronic kidney disease, Denmark, Dr. Thomas Hanke, Evotec, Harvard University, Joslin Diabetes Center, LAB eN² Program, Mass General Brigham, metabolic syndrome, Novo Nordisk, Obesity, partnership, type 1 diabetes, Uli Stilz
(IN BRIEF) Roche presented new data at the ASH 2024 meeting highlighting the effectiveness of its bispecific antibodies, Columvi and Lunsumio, in treating lymphomas. Long-term studies show durable remissions and immune system recovery with fixed-duration therapies, while real-world data emphasize … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged ASH 2024, Bispecific Antibodies, Columvi, Levi Garraway, Lunsumio, Lymphoma Treatment, Roche, safety
(IN BRIEF) Researchers at the Technical University of Munich (TUM) have developed a groundbreaking filtration method to remove harmful PFAS (“forever chemicals”) from drinking water. Using advanced metal-organic framework (MOF) compounds made of zirconium carboxylate, the filters are more effective … Read the full press release
Posted in Education, Food & Beverage, Germany, Healthcare, Science, Technology
Tagged activated carbon, advanced filtration, drinking water, environmental impact, filtration, forever chemicals, interdisciplinary research, metal-organic framework, MOF, PFAS, public health, Technical University of Munich, toxic chemicals, TUM, water contamination, water treatment, zirconium carboxylate, zirconium-based filters
(IN BRIEF) Novartis has announced promising 96-week results from the Phase III ASC4FIRST trial, showcasing Scemblix® (asciminib) as a superior treatment for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase (Ph+ CML-CP). Scemblix achieved significantly higher major … Read the full press release
Posted in Healthcare, Pharma & Biotech, Switzerland
Tagged 96-week results, asciminib, ASH Annual Meeting, chronic myeloid leukemia, CML care, discontinuation rate, imatinib, major molecular response, MMR, National Comprehensive Cancer Network, NCCN, newly diagnosed settings, Novartis, oncology, Ph+ CML-CP, Phase II ASC2ESCALATE trial, Phase III ASC4FIRST trial, Philadelphia chromosome-positive chronic myeloid leukemia, safety, Scemblix, Second-Line Treatment, severe adverse events, standard-of-care, TKIs, tolerability, tyrosine kinase inhibitors
(IN BRIEF) A transformative experience led a woman from the U.S. to Greece for a deep plane facelift performed by Dr. Papaioannou in Thessaloniki. Renowned as a discreet yet exceptional surgeon, Dr. Papaioannou combines artistry with surgical precision, restoring youthful … Read the full press release
Posted in Albania, Bulgaria, Cyprus, Greece, Healthcare, North Macedonia, Russia, Travel, United Kingdom
Tagged brow lift, clinic in Thessaloniki, deep plane facelift, Dr. Papaioannou, eye bag removal, facial rejuvenation, gifted surgeon in Greece, hidden gem, jowls lifted, lip lift, Papaioannoy Plastic Surgery, physical appearance, plastic surgery, restored youthful vibrancy, sagging skin tightened, whispered secret, wrinkles were gone
(IN BRIEF) A study led by the University of Bristol and published in Veterinary and Comparative Oncology has demonstrated that trained dogs can accurately detect bladder cancer in other dogs through urine samples. Using a non-invasive method, the dogs achieved … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged bladder cancer, Cancer-Detection Dogs, Claire Guest, Davies Veterinary Specialists, Dr. Nicola Rooney, Healthcare, Isabelle Desmas-Bazelle, Medical Detection Dogs, Other Dogs, partnership, Royal Veterinary College, University of Bristol, urine samples
(IN BRIEF) Trinity College Dublin’s School of Nursing & Midwifery has received the Bronze Athena Swan Award, recognizing its commitment to advancing gender equality and fostering inclusivity in education and healthcare. This achievement reflects the collaborative efforts of the School’s … Read the full press release
Posted in Awards, Business, Education, Financial, Healthcare, Industrial, Investment, Ireland, Management, News, Society
Tagged Amhairgín Ní Laoi, Awards, Bronze Athena Swan Award, Dr. Damien Brennan, Dr. Vivienne Brady, Education, gender equality, Healthcare, inclusivity, leadership, School of Nursing & Midwifery, society, Trinity College Dublin
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?